scispace - formally typeset
A

Aaron Lulla

Researcher at University of California, Los Angeles

Publications -  5
Citations -  344

Aaron Lulla is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Gene silencing & Dopaminergic. The author has an hindex of 4, co-authored 5 publications receiving 275 citations.

Papers
More filters
Journal ArticleDOI

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease

TL;DR: It is proposed that benomyl, via its bioactivated thiocarbamate sulfoxide metabolite, inhibits aldehyde dehydrogenase (ALDH), leading to accumulation of the reactive dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL), preferential degeneration of dopamine neurons, and development of PD.
Journal ArticleDOI

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity

TL;DR: The rapid onset of axonal pathology in this system, and the relatively moderate degree of cell death, provide a new model for the study of aSyn toxicity and protection and might have utility in screening for novel disease-modifying compounds.
Journal ArticleDOI

Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos

TL;DR: Data show that ziram is selectively toxic to DA neurons in vivo, and this toxicity is synuclein-dependent in zebrafish embryos, which has important implications for understanding the mechanisms by which pesticides may cause PD.
Journal ArticleDOI

Heme oxygenase-1 protects endothelial cells from the toxicity of air pollutant chemicals.

TL;DR: HO-1 expression protected HMECs from DEP-induced prooxidative and proinflammatory effects and could potentially serve as a therapeutic target in an attempt to inhibit the cardiovascular effects of ambient PM.